Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Triulzi, Tiziana ^a   Casalini, Patrizia ^a   Sandri, Marco ^a   Ratti, Manuela ^a   Carcangiu, Maria L ^a   Colombo, Mario P ^a   Balsari, Andrea ^b   Ménard, Sylvie ^a   Orlandi, Rosaria ^a   Tagliabue, Elda ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELL INTERACTION; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR PATHOLOGY; STROMA CELL;

AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; STROMAL CELLS; TRANSCRIPTOME; TUMOR BURDEN;

EID: 84874165459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056761     Document Type: Article

References (55)

1. Egeblad M, Nakasone ES, Werb Z, (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18: 884-901.
2. Pietras K, Ostman A, (2010) Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316: 1324-31.
3. Chang C, Werb Z, (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11: S37-S43.
4. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, et al. (1998) Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 143: 547-60.
5. Sherman-Baust CA, Weeraratna AT, Rangel LB, Pizer ES, Cho KR, et al. (2003) Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell 3: 377-86.
6. Pupa SM, Ménard S, Forti S, Tagliabue E, (2002) New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 192: 259-67.
7. McCready J, Arendt LM, Rudnick JA, Kuperwasser C, (2010) The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis. Breast Cancer Res 12: 205.
8. Condeelis J, Pollard JW, (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263-6.
9. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, et al. (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906.
10. Geho DH, Bandle RW, Clair T, Liotta LA, (2005) Physiological mechanisms of tumor-cell invasion and migration. Physiology (Bethesda) 20: 194-200.
11. Park CC, Bissell MJ, Barcellos-Hoff MH, (2000) The influence of the microenvironment on the malignant phenotype. Mol Med Today 6: 324-9.
12. Bissell MJ, Radisky D, (2001) Putting tumours in context. Nat Rev Cancer 1: 46-54.
13. Bergamaschi A, Tagliabue E, Sorlie T, Naume B, Triulzi T, et al. (2008) Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol 214: 357-67.
14. Szabo A, Perou CM, Karaca M, Perreard L, Palais R, et al. (2004) Statistical modeling for selecting housekeeper genes. Genome Biol 5: R59.
15. Van'T Veer LJ, Dai H, Van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-6.
16. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-41.
17. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-52.
18. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5: 607-16.
19. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, et al. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13: 3207-14.
20. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer I 98: 262-72.
21. Shabalin AA, Weigman VJ, Perou CM, Nobel AB, (2009) Finding large average submatrices in high dimensional data. Annals Applied Stat 3: 985-1012.
22. Cohen JA, (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20: 37-46.
23. Henning C, (2007) Cluster-wise assessment of cluster stability. Computational Stat & Data Anal 52: 258-271.
24. Brock G, Pihur V, Datta S, Datta S, (2008) clValid, an R package for cluster validation. J Stat Softw 25Available:http://www.jstatsoft.org/v25/i04.
25. Monti S, Tamayo P, Jill M, Golub T, (2003) Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn 52: 91-118.
26. Tibshirani R, Walther G, (2005) Cluster validation by prediction strength. J Comput Graph Stat 14: 511-528.
27. Liu Y, Hayes DN, Nobel A, Marron JS, (2008) Statistical significance of clustering for high-dimension, low-sample size data. J Am Stat Assoc 103: 1281-1293.
28. Cox DR, Oakes D (1984) Analysis of Survival Data. London: Chapman and Hall.
29. Hajian-Tilaki KO, Hanley JA, Joseph L, Collet JP, (1997) A comparison of parametric and nonparametric approaches to ROC analysis of quantitative diagnostic tests. Med Decis Making 17: 94-102.
30. StataCorp (2009) Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.
31. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-50.
32. Castellano G, Malaponte G, Mazzarino MC, Figini M, Marchese F, et al. (2008) Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin Cancer Res 14: 7470-80.
33. West RB, Nuyten DS, Subramanian S, Nielsen TO, Corless CL, et al. (2005) Determination of stromal signatures in breast carcinoma. PLoS Biol 3: e187.
34. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, et al. (2009) A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 15: 68-74.
35. Boersma BJ, Reimers M, Yi M, Ludwig JA, Luke BT, et al. (2008) A stromal gene signature associated with inflammatory breast cancer. Int J Cancer 122: 1324-32.
36. Casey TM, Eneman J, Crocker A, White J, Tessitore J, et al. (2008) Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat 110: 39-49.
37. Kalluri R, Zeisberg M, (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
38. Myhre S, Mohammed H, Tramm T, Alsner J, Finak G, et al. (2010) In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome. PLoS ONE 5: e14002.
39. Xu R, Boudreau A, Bissell MJ, (2009) Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metast Rev 28: 167-76.
40. Madeo A, Maggiolini M, (2010) Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res 70: 6036-46.
41. Yan DJ, Chen ZW, (2010) 17beta-estradiol increased the expression of daintain/AIF-1 in RAW264.7 macrophages. Biosci Biotechnol Biochem 74: 2103-5.
42. Calippe B, Douin-Echinard V, Delpy L, Laffargue M, Lelu K, et al. (2010) 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J Immunol 185: 1169-76.
43. Roberts AB, Wakefield LM, (2003) The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 100: 8621-3.
44. Verrecchia F, Mauviel A, (2002) Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118: 211-5.
45. Podhajcer OL, Benedetti LG, Girotti MR, Prada F, Salvatierra E, et al. (2008) The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 27: 691-705.
46. Schiemann BJ, Neil JR, Schiemann WP, (2003) SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Mol Biol Cell 14: 3977-88.
47. Briggs J, Chamboredon S, Castellazzi M, Kerry JA, Bos TJ, (2002) Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells. Oncogene 21: 7077-91.
48. Egeblad M, Rasch MG, Weaver VM, (2010) Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22: 697-706.
49. Wang W, Wyckoff JB, Frohlich VC, Oleynikov Y, Huttelmaier S, et al. (2002) Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 62: 6278-88.
50. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, et al. (2008) Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 10: R65.
51. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 101: 9309-14.
52. Sangaletti S, Gioiosa L, Guiducci C, Rotta G, Rescigno M, et al. (2005) Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J Cell Sci 118: 3685-94.
53. Kopfstein L, Christofori G, (2006) Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 63: 449-68.
54. Venet D, Dumont JE, Detours V, (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 7: e1002240.
55. Kim Y, Wallace J, Li F, Ostrowski M, Friedman A, (2010) Transformed epithelial cells and fibroblasts/myofibroblasts interaction in breast tumor: a mathematical model and experiments. J Math Biol 61: 401-21.